1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Renal Insufficiency Global Clinical Trials Review, H2, 2015

Renal Insufficiency Global Clinical Trials Review, H2, 2015

  • September 2015
  • -
  • Global Data
  • -
  • 120 pages

Renal Insufficiency Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Renal Insufficiency Global Clinical Trials Review, H2, 2015" provides an overview of Renal Insufficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Insufficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Renal Insufficiency Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Renal Insufficiency 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Renal Insufficiency to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Renal Insufficiency to Genito Urinary System And Sex Hormones Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Renal Insufficiency 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Renal Insufficiency Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Merck and Co., Inc. 34
Clinical Trial Overview of Merck and Co., Inc. 34
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Amgen Inc. 38
Clinical Trial Overview of Amgen Inc. 38
Bayer AG 39
Clinical Trial Overview of Bayer AG 39
Astellas Pharma Inc. 40
Clinical Trial Overview of Astellas Pharma Inc. 40
Johnson and Johnson 41
Clinical Trial Overview of Johnson and Johnson 41
C. H. Boehringer Sohn AG and Co. KG 42
Clinical Trial Overview of C. H. Boehringer Sohn AG and Co. KG 42
AbbVie Inc. 43
Clinical Trial Overview of AbbVie Inc. 43
F. Hoffmann-La Roche Ltd. 44
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 44
Clinical Trial Overview of Top Institutes / Government 45
Aarhus University 45
Clinical Trial Overview of Aarhus University 45
Academic Hospital Maastricht 46
Clinical Trial Overview of Academic Hospital Maastricht 46
Academic Medical Center 47
Clinical Trial Overview of Academic Medical Center 47
American Academy of Family Physicians 48
Clinical Trial Overview of American Academy of Family Physicians 48
Asan Medical Center 49
Clinical Trial Overview of Asan Medical Center 49
Assiut University 50
Clinical Trial Overview of Assiut University 50
Austin Health 51
Clinical Trial Overview of Austin Health 51
Austrian Forum Against Cancer 52
Clinical Trial Overview of Austrian Forum Against Cancer 52
Barnes-Jewish Hospital 53
Clinical Trial Overview of Barnes-Jewish Hospital 53
Baylor College of Medicine 54
Clinical Trial Overview of Baylor College of Medicine 54
Five Key Clinical Profiles 55
Appendix 117
Abbreviations 117
Definitions 117
Research Methodology 118
Secondary Research 118
About GlobalData 119
Contact Us 119
Disclaimer 119
Source 120

List of Tables
Renal Insufficiency Therapeutics, Global, Clinical Trials by Region, 2015* 7
Renal Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Renal Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Renal Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Renal Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Renal Insufficiency Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Renal Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Renal Insufficiency Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Renal Insufficiency to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Renal Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Renal Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Renal Insufficiency to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Renal Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Renal Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Renal Insufficiency Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Renal Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Renal Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Renal Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Renal Insufficiency Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Renal Insufficiency Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Renal Insufficiency Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Renal Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Renal Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
Renal Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Renal Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Renal Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 34
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 36
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 37
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 38
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015* 39
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 40
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 41
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG and Co. KG, 2015* 42
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 43
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 44
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015* 45
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Hospital Maastricht, 2015* 46
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 47
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by American Academy of Family Physicians, 2015* 48
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015* 49
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Assiut University, 2015* 50
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Austin Health, 2015* 51
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Austrian Forum Against Cancer, 2015* 52
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnes-Jewish Hospital, 2015* 53
Renal Insufficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2015* 54

List of Figures
Renal Insufficiency Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Renal Insufficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Renal Insufficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Renal Insufficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Renal Insufficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Renal Insufficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Renal Insufficiency Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Renal Insufficiency Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Renal Insufficiency to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Renal Insufficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Renal Insufficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Renal Insufficiency to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Renal Insufficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Renal Insufficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Renal Insufficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Renal Insufficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Renal Insufficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Renal Insufficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Renal Insufficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Renal Insufficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
Renal Insufficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Renal Insufficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Renal Insufficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 118

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.